Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0XKJAR)
| ADC Name |
Tigatuzumab-ADC-Tb3-8
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Tigatuzumab ADC Tb3 8
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2-8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Tigatuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Tigatuzumab-ADC-Tb3-8 payload
|
|||||
| Linker Name |
Tigatuzumab-ADC-Tb3-8 linker
|
|||||